Baixar PDF

Outros usuários também visualizaram estes artigos

LONG-TERM SAFETY AND EFFICACY OF DEFERIPRONE FOR THE TREATMENT OF CHRONICALLY TRANSFUSED, IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS MPA Verissimo; MS Elalfy; M Hamdy; A El-Beshlawy; F Ebeid; J Kanter; S Williams; D Lee; F Tricta; JL Kwiatkowski;
Hematol Transfus Cell Ther. 2021;43 Supl 1:S23-4
REAL-WORLD SAFETY PROFILE OF TWICE-DAILY DEFERIPRONE FOR IRON OVERLOAD IN US PATIENTS WITH THALASSEMIA, SICKLE CELL DISEASE OR OTHER ANEMIAS S Sheth; A Lal; A Appiah-Kubi; SA Peslak; NT Temin; RR Palhares; T Coates;
Hematol Transfus Cell Ther. 2025;47 Supl 3:
PROFILAXIA COM EMICIZUMABE EM PACIENTES COM HEMOFILIA A GRAVE: EXPERIÊNCIA DO HOSPITAL BOLDRINI MC Della Piazza; LCM Gusmão; M Verissimo; AC Azevedo; CC Omae; JC Yajima; TN Ferreira; SR Brandalise;
Hematol Transfus Cell Ther. 2025;47 Supl 3: